Literature DB >> 28864370

Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis.

Jiancheng Zhao1, Sai Li2, Linan Ren3, Xiaozhong Guo4, Xingshun Qi5.   

Abstract

BACKGROUND: Increased pro-brain natriuretic peptide (pro-BNP) or troponin T-hypersensitivity (TnT-HSST) levels are common in liver cirrhosis. We conducted a retrospective observational study aimed to evaluate the correlation of pro-BNP and TnT-HSST levels with the clinical characteristics, laboratory data and in-hospital outcomes of patients with liver cirrhosis.
MATERIALS AND METHODS: We selected cirrhotic patients admitted to our hospital between January 2011 and June 2014. All eligible patients had pro-BNP or TnT-HSST data, or both. The pro-BNP and TnT-HSST data were further divided according to the presence of cardiac diseases.
RESULTS: The prevalence of pro-BNP level >900pg/mL was 41.72% (63 of 151 patients). The prevalence of TnT-HSST level >0.05ng/mL was 11.22% (45 of 401 patients). In the overall analysis, pro-BNP level significantly correlated with red blood cell (RBC), platelet, ascites, blood urea nitrogen (BUN), creatinine (Cr), Child-Pugh score, model for end-stage liver disease (MELD) score and in-hospital death; TnT-HSST level significantly correlated with white blood cell, ascites, albumin (ALB), BUN, Cr, Child-Pugh score, MELD score and in-hospital death. In patients with cardiac diseases, pro-BNP level significantly correlated with RBC, ascites, BUN, Cr, Child-Pugh score and MELD score; TnT-HSST level significantly correlated with sex, ascites, white blood cell, ALB, BUN, Cr, Child-Pugh score, MELD score and in-hospital death. In patients without cardiac diseases, pro-BNP level significantly correlated with ascites, RBC, platelet, BUN, Cr, MELD score and in-hospital death; TnT-HSST level significantly correlated with age, ascites, RBC, ALB, BUN, Cr, Child-Pugh score, MELD score and in-hospital death.
CONCLUSIONS: Pro-BNP and TnT-HSST levels significantly correlated with the severity of liver dysfunction and in-hospital mortality in cirrhosis.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhotic cardiomyopathy; Liver cirrhosis; Pro-BNP; Prognosis; TnT-HSST

Mesh:

Substances:

Year:  2017        PMID: 28864370     DOI: 10.1016/j.amjms.2017.04.005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

Review 1.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

2.  Correlation of Serum Cardiac Markers with Acute Decompensating Events in Liver Cirrhosis.

Authors:  Miaomiao Li; Zeqi Guo; Dan Zhang; Xiangbo Xu; Fernando Gomes Romeiro; Andrea Mancuso; Jingqiao Zhang; Ruirui Feng; Xinmiao Zhou; Cen Hong; Xingshun Qi
Journal:  Gastroenterol Res Pract       Date:  2020-09-24       Impact factor: 2.260

3.  B-type natriuretic peptide (BNP) predicts 90-day mortality and need for paracentesis in cirrhotic patients without systolic heart failure.

Authors:  Tiago Araujo; Ishaan Vohra; Pedro Palacios; Vatsala Katiyar; Estefania Flores; Tejinder Randhawa; Yuchen Wang; Yazan Abu-Omar; Vijaya Mukthinuthalapati; Hemant Mutneja; Sanjay A Patel; Bashar Attar
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

4.  Preoperative high-sensitivity troponin I and B-type natriuretic peptide, alone and in combination, for risk stratification of mortality after liver transplantation.

Authors:  Young-Jin Moon; Hye-Mee Kwon; Kyeo-Woon Jung; Kyoung-Sun Kim; Won-Jung Shin; In-Gu Jun; Jun-Gol Song; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2020-08-26

5.  Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension.

Authors:  Dhiraj Tripathi; Adrian J Stanley; Peter C Hayes; Simon Travis; Matthew J Armstrong; Emmanuel A Tsochatzis; Ian A Rowe; Nicholas Roslund; Hamish Ireland; Mandy Lomax; Joanne A Leithead; Homoyon Mehrzad; Richard J Aspinall; Joanne McDonagh; David Patch
Journal:  Gut       Date:  2020-02-29       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.